Atlas Trials

Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

Clinical trial NCT00266097 · COMPLETED

Trial details

NCT number
NCT00266097
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
Start date
2004-08-01
Primary completion
2009-03-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.